Insiders · Profile

WAGNER CHARLES F JR

EVP, CO & FO at Vertex Pharmaceuticals · EVP & Chief Financial Officer at BRUKER. Filing since 17 Mar 2015. CIK 0001223348

Company
Date
Role
Action
Shares
Amount
Of holding
6 Jan 2026
EVP, CO & FO
Sold on a plan
9,532
$4.39M
20.2%
3 Dec 2025
EVP, CO & FO
Sold on a plan
14,000
$6.38M
27.1%
10 Mar 2025
EVP & Chief Financial Officer
Sold on a plan
3,298
$1.65M
6.0%
11 Nov 2024
EVP & Chief Financial Officer
Sold on a plan
3,000
$1.55M
6.4%
3 Jun 2024
EVP & Chief Financial Officer
Sold on a plan
3,250
$1.50M
6.5%
28 May 2024
EVP & Chief Financial Officer
Sold on a plan
3,250
$1.48M
6.1%
2 Jan 2024
EVP & Chief Financial Officer
Sold on a plan
3,000
$1.22M
6.4%
20 Nov 2023
EVP & Chief Financial Officer
Sold on a plan
3,000
$1.05M
6.0%
24 Mar 2023
EVP & Chief Financial Officer
Sold on a plan
1,768
$539.91K
3.4%
17 Mar 2023
EVP & Chief Financial Officer
Sold on a plan
2,000
$592.79K
3.7%
13 Mar 2023
EVP & Chief Financial Officer
Sold, plan not stated
2,666
$783.35K
4.8%
10 Mar 2023
EVP & Chief Financial Officer
Sold, plan not stated
2,088
$604.71K
3.6%
2 May 2022
EVP & Chief Financial Officer
Sold, plan not stated
343
$88.78K
0.8%
1 Apr 2022
EVP & Chief Financial Officer
Sold, plan not stated
2,582
$683.60K
5.6%
17 Mar 2022
EVP & Chief Financial Officer
Sold, plan not stated
3,171
$793.22K
6.4%
2 Feb 2022
EVP & Chief Financial Officer
Sold, plan not stated
2,944
$736.21K
4.9%
10 Jul 2020
EVP & Chief Financial Officer
Sold, plan not stated
700
$205.21K
4.2%
17 Mar 2015
EVP & Chief Financial Officer
Sold, plan not stated
19,000
$360.49K
16.0%
18 decisions on file.